SXTPW
Financials
- Market Capitalization 3.6225 M
- Employee 3
- Founded 2010
- CEO N/A
- Website www.60degreespharma.com
- Headquarter Delaware, United States
- FIGI BBG00NXBJGQ4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 7393 |  MLECW Moolec Science SA - Warrant | 0.0158 USD | 0.00% | -0.63% | -7.60% | +50.48% | 4.94 M USD | ||
| 7402 |  REVBW Revelation Biosciences, Inc. - Warrant | 0.0065 USD | 0.00% | 0.00% | -33.67% | -41.44% | 4.18 M USD | ||
| 7418 |  SLXNW Silexion Therapeutics Corp - Warrant | 0.0124 USD | -2.36% | -11.43% | -38.61% | -64.67% | 2.00 M USD | ||
| 7423 |  CDTTW CDT Equity Inc. - Warrant | 0.0108 USD | +14.89% | +0.93% | -0.92% | -28.00% | 1.33 M USD |
Frequently asked questions about 60 Degrees Pharmaceuticals, Inc. Common Stock
What is the 60 Degrees Pharmaceuticals, Inc. Common Stock stock price today?
The current price of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTPW) is 0.0373. Over the past 24 hours, the stock has changed by -5.33%. Follow the SXTPW chart for real-time price dynamics.
What is the stock ticker of 60 Degrees Pharmaceuticals, Inc. Common Stock?
60 Degrees Pharmaceuticals, Inc. Common Stock trades under the ticker SXTPW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is 60 Degrees Pharmaceuticals, Inc. Common Stock stock going up?
SXTPW has changed by +5.07% over the last week, +33.21% over the last month, and -58.83% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of 60 Degrees Pharmaceuticals, Inc. Common Stock?
60 Degrees Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 3.62 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were 60 Degrees Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, 60 Degrees Pharmaceuticals, Inc. Common Stock reported earnings of -0.9 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was 60 Degrees Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
60 Degrees Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 207.9 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was 60 Degrees Pharmaceuticals, Inc. Common Stock net income for the last quarter?
60 Degrees Pharmaceuticals, Inc. Common Stock reported net income of -2.26 M for the last quarter. The previous quarter showed -2.09 M, which means net income changed by -8.39%.
How many employees does 60 Degrees Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, 60 Degrees Pharmaceuticals, Inc. Common Stock has 3 employees. Workforce size can provide additional context about the company's scale and operations.
What is 60 Degrees Pharmaceuticals, Inc. Common Stock EBITDA?
60 Degrees Pharmaceuticals, Inc. Common Stock EBITDA is -2.25 M, and its EBITDA margin is -1 084.26%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy 60 Degrees Pharmaceuticals, Inc. Common Stock stock?
You can buy 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTPW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in 60 Degrees Pharmaceuticals, Inc. Common Stock stock?
Investing in 60 Degrees Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SXTPW chart and related analysis on metatrader.com as part of your research.